These findings along with the positive correlation of Mb with ERα, the better tumour differentiation with improved prognosis and the negative correlation with the basal phenotype marker CK5/6 all point to Mb as a marker of luminal tumour differentiation. The gene discussed is MB; the disease is neoplasm.